LINK ALTERNATIF MBL77 OPTIONS

Not all individuals with CLL demand therapy. Even with all new developments, the iwCLL however endorses watchful observation for clients with asymptomatic illness.86 This suggestion is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two t